Accès à distance ? S'identifier sur le proxy UCLouvain
A NEW FUNCTIONAL CYP3A4 POLYMORPHISM (CYP3A4*22) IS ASSOCIATED WITH INCREASED RISK OF DELAYED GRAFT FUNCTION AND WORSE RENAL FUNCTION IN CYCLOSPORIN-TREATED KIDNEY TRANSPLANT RECIPIENTS.
Onglets principaux
| Type de document | Communication à un colloque (Conference Paper) – Poster |
|---|---|
| Année de publication | 2012 |
| Langue | Anglais |
| Conférence | "113th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)", Washington, USA (du 14/03/2012 au 17/03/2012) |
| Information sur le périodique | "Clinical Pharmacology and Therapeutics" - Vol. 91, no.S1, p. S107 (mars 2012) |
| Peer reviewed | oui |
| issn | 0009-9236 |
| e-issn | 1532-6535 |
| Editeur | Nature Publishing Group ((United States) New York) |
| Statut de la publication | Publié |
| Affiliations | UCL - SSS/LDRI - Louvain Drug Research Institute |
| Liens |
| Référence bibliographique | Elens, Laure. A NEW FUNCTIONAL CYP3A4 POLYMORPHISM (CYP3A4*22) IS ASSOCIATED WITH INCREASED RISK OF DELAYED GRAFT FUNCTION AND WORSE RENAL FUNCTION IN CYCLOSPORIN-TREATED KIDNEY TRANSPLANT RECIPIENTS. .113th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT) (Washington, USA, du 14/03/2012 au 17/03/2012). In: Clinical Pharmacology and Therapeutics, Vol. 91, no.S1, p. S107 (mars 2012) |
|---|---|
| Permalien | http://hdl.handle.net/2078.1/161907 |